Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Manuel Valdebran has a total of 131 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Human dorsal root ganglion–based itch subcluster mapping and pathway analysis through single-nucleus RNA sequencing

    by Tyler C. Beck, Jordan Morningstar, Stefano Berto, Shawn Afvari, Katie A. O’COnnell, Manuel Valdebran, Russell A. Norris, Shawn G. Kwatra

  • Open Access

    Dermoscopy of nailfold capillaries and Gottron's papules in a 15-year-old patient

    by Ludwin Castro, Manuel Valdebran, Katherine G. Meléndez, Johanna Cristales, Luz Ely Cerritos

  • Mitochondrial dysfunction in metabolic syndrome and inflammatory skin disease

    by Victoria Palmer, Tyler Beck, Sarah Shareef, John Helmy, Manuel Valdebran

    Metabolic syndrome is a multifactorial process characterized by obesity, hypertension, hyperlipidemia, hyperglycemia, and insulin resistance, significantly increasing the risk of cardiovascular disease (CVD), type 2 diabetes mellitus, and other chronic health conditions. The prevalence of metabolic syndrome is rising globally due to sedentary lifestyles and poor dietary habits. Inflammatory skin diseases, including psoriasis, atopic dermatitis (AD), rosacea, acne vulgaris, lichen planus, acanthosis nigricans, androgenetic alopecia and hidradenitis suppurativa are closely linked to metabolic syndrome and mitochondrial dysfunction. These skin conditions are characterized by dysregulated immune responses and increased activation of inflammatory cytokines and immune cells. Additionally, mechanisms resulting in the induction of mitochondrial apoptosis influence the pathogenesis of these inflammatory skin diseases, while oxidative stress, inflammation and insulin resistance further interlink mitochondrial dysfunction and metabolic syndrome. Understanding the role of mitochondrial dysfunction in the pathogenesis of metabolic syndrome and inflammatory skin diseases is crucial for developing targeted therapies. Further research is needed to explore the contributing pathophysiology and develop strategies for preventing and treating these conditions. Genomic studies have also identified mutations associated with mitochondrial dysfunction and insulin resistance, offering potential targets for personalized therapies. Key words: Mitochondrial dysfunction, Metabolic syndrome, Insulin resistance, Autoinflammatory skin disease, Oxidative stress


  • Hidradenitis suppurativa and diet: A cross-sectional analysis of reddit and review of the literature

    by Maxwell Green, Aileen Feschuk, Manuel Valdebran

    Hidradenitis suppurativa and diet: A cross-sectional analysis of reddit and review of the literature

  • Evaluation and management of cardiovascular disease and metabolic syndrome in pediatric-adolescent patients with psoriasis

    by Victoria Palmer, Manuel Valdebran

    Psoriasis is strongly associated with cardiovascular disease (CVD) and metabolic syndrome, with pediatric and adolescent patients having an increased risk of each compared to the general population. This increased risk is based on shared underlying genetic and cytokine profiles, as well as similar environmental risks. Many screening guidelines do not address the development of CVD and metabolic syndrome in these predisposed patients, particularly in the adolescent population. These deficits are evidenced by the absence of validated 10-year CVD risk calculators for pediatric and adolescent patients with chronic inflammatory diseases, as well as insufficient screening guidelines for insulin resistance in patients with psoriasis. This manuscript aims to contribute literature regarding allopathic and lifestyle recommendations to the most recent 2017 consensus guideline for the pediatric/adolescent population with psoriasis. PubMed, COCHRANE Database of Systematic Reviews and Google Scholar were reviewed by a panel of clinicians with clinical and research expertise in psoriasis and pediatric subspecialties. The patient-centered Strength of Recommendation Taxonomy (SORT) method was utilized to grade the quality of the evidence available. Updates in management surrounding the role of lipoprotein(a) in lipid panels, recommendations for exercise and weight management to decrease insulin resistance, as well as guidance for heart rate and blood pressure management were discussed. Screening and managing pediatric and adolescent patients with psoriasis for the associated comorbidities of CVD and metabolic syndrome is imperative. Future high-quality studies are needed to strengthen the evidence provided throughout this review, which acts as a framework for clinical practice. Key words: Psoriasis, Comorbidity, Exercise, Treatment, Coronary heart disease

  • Diet, sleep, and exercise in inflammatory skin diseases

    by Shawn Afvari, Tyler C. Beck, Maryia Kazlouskaya, Ryan Afrahim, Manuel Valdebran

    Inflammatory skin conditions are significantly impacted by lifestyle habits, particularly those related to diet, exercise, and sleep. Although ancient cultures emphasized the importance of lifestyle behaviors as both etiology and therapy in disease, modern medicine often overlooks nonpharmacological therapy. However, recent studies show that diet can have a significant impact on inflammatory skin diseases such as psoriasis, hidradenitis suppurativa, and atopic dermatitis. Foods high in glycemic index, advanced glycation end-products, and omega-6 polyunsaturated fatty acids are associated with obesity and systemic inflammation, which can exacerbate inflammatory skin diseases. In addition, lifestyle behaviors such as exercise and sleep have been shown to have positive effects on inflammatory skin diseases. This review aims to highlight the importance of lifestyle behaviors in the context of inflammation and inflammatory dermatoses. Key words: Diet, Exercise, Sleep, Psoriasis, Inflammation, Skin


  • Central centrifugal cicatricial alopecia: A call for additional literature in the pediatric population

    by Victoria Palmer, Manuel Valdebran

    Central centrifugal cicatricial alopecia: A call for additional literature in the pediatric population

  • Open Access

    Central Centrifugal Cicatricial Alopecia in the Adolescent Population: An Overview of Available Literature

    by Victoria Palmer, Manuel Valdebran

    Central centrifugal cicatricial alopecia (CCCA) is a lymphocytic scarring alopecia that predominantly affects women of African descent. Recent studies have demonstrated prevalence in children and adolescents, as well as Asian populations. A thorough search of Pubmed, Cochrane Database of Systematic Reviews, OVID Medline and Google Scholar was conducted using keywords such as “central centrifugal cicatricial alopecia”, “scarring hair loss”, “scarring alopecia”, “hot comb alopecia”, “pediatric” and “adolescent”. The results yielded few articles in the literature that directly addressed CCCA in the adolescent population, with three articles providing details of the presentation in the form of case series and retrospective reviews. The presentation in the adolescent population was found to be varied, ranging from asymptomatic to symptomatic and involving diffuse to patchy hair loss in only the vertex and/or frontal and parietal scalp. Genetic and environmental etiologies were found to be statistically significant, and markers of metabolic dysregulation predisposing patients to diabetes mellitus and breast cancer were also uncovered. The differential diagnosis of patients who present with hair loss in the adolescent population should therefore be broad, and a low threshold for biopsies should be adopted to confirm CCCA in suspected patients. This will have future implications for reduced morbidity and public health.


  • Open Access

    Immunoglobulin G4-Related Disease-Associated Dermatitis with Pruritus: A Positive Response to Dupilumab

    by Tyler C. Beck, John Plante, India Robinson, Katsiaryna Khatskevich, Jessica A. Forcucci, Manuel Valdebran

    Immunoglobulin G4-related disease (IgG4-RD) is a rare fibro-inflammatory condition characterized by IgG4-expressing plasma cell infiltration of the skin and other organs, leading to profound itchiness. Oral corticosteroids are the first-line therapy for IgG4-RD but relapses and potential side effects are common. In this case, we discuss a patient with a hyperpigmented, scaling dermatitis on his arms, back, and chest with lichen amyloidosis (LA) that incompletely responded to corticosteroids. He had reduced quality of life secondary to chronic pruritus. Dupilumab, an IL-4 and IL-13 inhibitor, was initiated. He experienced a transient worsening, followed by complete resolution of his itch with remission of his rash. While the pathogenesis of IgG4-RD is not entirely understood, a T-helper 2 (Th2) immune response has been implicated, with interleukins (IL) 4, 5, 10, and 13 playing a role in IgG4 class switch, resulting in eosinophilia and elevated IgE. The strong response of dupilumab in this case may provide evidence in favor of the involvement of IL-4 and IL-13 in the pathogenesis of cutaneous IgG4-RD. Future clinical studies involving larger patient populations may be warranted.